A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles

• Published in: Applied microbiology and biotechnology 2017-04, Vol.101 (8), p.3143-3152
• Main Authors: Leuchs, Barbara, Frehtman, Veronika, Riese, Markus, Müller, Marcus, Rommelaere, Jean
• Format: Article
• Language: English
• Subjects: Animals; Anion exchange; Biomedical and Life Sciences; Biotechnological Products and Process Engineering; Biotechnology; Cancer; Capsid - chemistry; Capsid - virology; Cations; Centrifugation; Centrifuges; Chromatography; Chromatography, Ion Exchange - methods; Clinical trials; Filtration; Filtration - methods; Genomes; Good Manufacturing Practice; H-1 parvovirus - chemistry; H-1 parvovirus - isolation & purification; H-1 parvovirus - ultrastructure; Isoelectric Focusing - methods; Isoelectric Point; Life Sciences; Microbial Genetics and Genomics; Microbiology; Microscopy, Electron; Oncology; Proteins; Rats; Rodents; Sodium chloride; Studies; Virology
• ISSN: 0175-7598; 1432-0614
• DOI: 10.1007/s00253-016-8071-x

The rodent protoparvovirus H-1PV, with its oncolytic and oncosuppressive properties, is a promising anticancer agent currently under testing in clinical trials. This explains the current demand for a scalable, good manufacturing practice-compatible virus purification process yielding high-grade pure infectious particles and overcoming the limitations of the current system based on density gradient centrifugation. We describe here a scalable process offering high purity and recovery. Taking advantage of the isoelectric point difference between full and empty particles, it eliminates most empty particles. Full particles have a significantly higher cationic charge than empty ones, with an isoelectric point of 5.8–6.2 versus 6.3 (as determined by isoelectric focusing and chromatofocusing). Thanks to this difference, infectious full particles can be separated from empty particles and most protein impurities by Convective interaction media ® diethylaminoethyl (DEAE) anion exchange chromatography: applying unpurified H-1PV to the column in 0.15 M NaCl leaves, the former on the column and the latter in the flow through. The full particles are then recovered by elution with 0.25 M NaCl. The whole large-scale purification process involves filtration, single-step DEAE anion exchange chromatography, buffer exchange by cross-flow filtration, and final formulation in Visipaque/Ringer solution. It results in 98% contaminating protein removal and 96% empty particle elimination. The final infectious particle concentration reaches 3.5E10 plaque forming units (PFU)/ml, with a specific activity of 6.8E11 PFU/mg protein. Overall recovery is over 40%. The newly established method is suitable for use in commercial production.